STATE STREET CORP - PROCESSA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$14,316
+31.2%
42,7860.0%0.00%
Q3 2023$10,910
-48.7%
42,7860.0%0.00%
Q2 2023$21,286
-6.1%
42,7860.0%0.00%
Q1 2023$22,672
-75.9%
42,786
-50.0%
0.00%
Q4 2022$94,130
-3.0%
85,572
+100.0%
0.00%
Q3 2022$97,000
-19.2%
42,7860.0%0.00%
Q2 2022$120,000
-4.0%
42,786
+3.1%
0.00%
Q1 2022$125,000
-38.4%
41,4860.0%0.00%
Q4 2021$203,000
-43.0%
41,4860.0%0.00%
Q3 2021$356,000
+161.8%
41,486
+149.9%
0.00%
Q2 2021$136,00016,6000.00%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Solas Capital Management, LLC 196,150$961,0000.68%
AIGH Capital Management LLC 303,703$1,488,0000.45%
Worth Venture Partners, LLC 70,954$348,0000.17%
ESSEX INVESTMENT MANAGEMENT CO LLC 73,180$359,0000.04%
Verdence Capital Advisors LLC 63,227$310,0000.04%
Coastal Bridge Advisors, LLC 32,500$159,0000.03%
Vectors Research Management, LLC 4,000$20,0000.00%
Janney Montgomery Scott LLC 46,231$227,0000.00%
UBS Group AG 218$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 64,902$318,0000.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders